Profil
Wolfgang Künnecke is associated with two companies, Aureum Realwert AG and 908 Devices GmbH.
He is the founder of both companies.
Aureum Realwert AG was founded in 1991, and Dr. Künnecke held the title of Chairman-Management Board.
908 Devices GmbH is founded in 2003, and Dr. Künnecke currently holds the title of Chairman & Managing Director.
Postes actifs de Wolfgang Künnecke
| Sociétés | Poste | Début |
|---|---|---|
908 Devices GmbH
 908 Devices GmbH Medical SpecialtiesHealth Technology Part of 908 Devices, Inc., 908 Devices GmbH is a German company that manufactures and supplies analytical devices for biotechnology monitoring. The private company is based in Braunschweig, Germany. The company was founded in 2003 by Wolfgang Künnecke. Wolfgang Künnecke has been the CEO since 2003. 908 Devices was acquired by 908 Devices, Inc. on August 09, 2022 for $17.68 million. | Directeur Général | 01/01/2003 |
Anciens postes connus de Wolfgang Künnecke
| Sociétés | Poste | Fin |
|---|---|---|
| AUREUM REALWERT AG | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Aureum Realwert AG
 Aureum Realwert AG Financial ConglomeratesFinance Aureum Realwert AG engages in the acquisition, administration and sale of financial assets such as investments in other companies. It invests in real assets including precious metals, raw materials, and real estate. The company was founded by Wolfgang Kuennecke on November 18, 1991 and is headquartered in Berlin, Germany. | Finance |
908 Devices GmbH
908 Devices GmbH Medical SpecialtiesHealth Technology Part of 908 Devices, Inc., 908 Devices GmbH is a German company that manufactures and supplies analytical devices for biotechnology monitoring. The private company is based in Braunschweig, Germany. The company was founded in 2003 by Wolfgang Künnecke. Wolfgang Künnecke has been the CEO since 2003. 908 Devices was acquired by 908 Devices, Inc. on August 09, 2022 for $17.68 million. | Health Technology |
